Galanin (1-13)-Bradykinin (2-9) amide

Supplier: BACHEM AMERICAS INC

4020106.0500 4020106.1000
H-1346.0500BAEA 391.92 CAD
H-1346.0500BA H-1346.1000BA
Galanin (1-13)-Bradykinin (2-9) amide
Proteins and Peptides

The galanin antagonist M35, which binds with high specificity and affinity to galanin binding sites, has been administered to rats to test the functional consequences of the galanin receptor blockade in a spatial learning task. The results suggest that galanin antagonists might provide a new principle in the treatment of dementia and related disorders. M35 (but not M40 or C7) ameliorated cerulein-induced acute pancreatitis in mice.

Order Now


Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR